Today: 21 March 2026
Browse Category

ASX:BGA 25 July 2025

Space Race Heats Up: Russia’s 21-Satellite Launch, Amazon’s $140 M Bet, and a New Artemis Ally

Space Race Heats Up: Russia’s 21-Satellite Launch, Amazon’s $140 M Bet, and a New Artemis Ally

A Russian Soyuz-2.1b rocket launched 21 satellites from Vostochny Cosmodrome on July 25, including two Ionosfera-M space weather satellites and Iran’s Nahid-2. The Ionosfera-M pair will study solar wind effects on radio communications. Senegal signed the Artemis Accords, becoming the 56th member. SpaceX launched NASA’s TRACERS mission from Vandenberg on July 23 and plans a Starlink launch from Cape Canaveral on July 26.

Stock Market Today

  • Abbott Laboratories (ABT) Shares Dip Amid Valuation Debate: Is This a Buying Opportunity?
    March 21, 2026, 1:04 AM EDT. Abbott Laboratories' (ABT) share price has declined 15% year-to-date, trading around US$105, sparking debate on whether it's a value trap or a long-term opportunity. Analysis using discounted cash flow (DCF) models estimates the stock's intrinsic value at approximately $164.42 per share, signalling a potential 35.9% undervaluation. The healthcare giant's recent performance lags peers amid investor caution over medical equipment demand and capital allocation strategies. Analyst forecasts project free cash flow reaching $11.46 billion by 2028, supporting bullish valuation metrics despite recent stock weakness. Investors are advised to consider these fundamentals alongside sector risks when assessing ABT shares.
Go toTop